Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02320812 · ClinicalTrials.gov registry record · Phase 1
Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa
A Phase 1 study, sponsored by jCyte.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT02320812: Completed Phase 1 study, sponsored by jCyte.
NCT02320812 is a Phase 1 study that has completed, run by jCyte. The registered enrollment target is 28 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02320812, a Phase 1 study, has completed, sponsored by jCyte.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study evaluates the safety and potential activity of a single dose of live human retinal progenitor cells (jCell) administered to adults with retinitis pigmentosa. Four different dose levels of cells will be assessed in each of two groups of patients.
Primary Outcome
proportion of subjects with treatment emergent adverse events (TEAE), related TEAE and severe TEAE
Interventions
- BIOLOGICAL human retinal progenitor cells
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-07-19 |
| Phase | Phase 1 |
What the finished NCT02320812 record still lists
NCT02320812 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which human retinal progenitor cells is the first listed.
NCT02320812 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02320812 about?
NCT02320812 is a clinical study titled "Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa". This study evaluates the safety and potential activity of a single dose of live human retinal progenitor cells (jCell) administered to adults with retinitis pigmentosa. Four different dose levels of cells will be assessed in each of two groups of patients.
What is the current status of trial NCT02320812?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2015-06. Estimated completion is 2017-07-19.
What interventions are being tested in trial NCT02320812?
The interventions under investigation include: human retinal progenitor cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT02320812?
This trial is sponsored by jCyte, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02320812's enrollment target sits among peer trials
28 1447th of 2000 higher than 538 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia